CTD MT 6.25/50/40 MG (Chlorthalidone (6.25mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg))

CTD-MT 6.25/50/40 Tablet ER is a composite pharmaceutical formulation indicated for managing hypertension, commonly known as high blood pressure. This medication functions by dilating blood vessels, which enhances the heart’s ability to circulate blood throughout the system more effectively. Additionally, it aids in the elimination of excess fluid and specific electrolytes from the body. It is advisable to take the tablet consistently at the same time daily, regardless of meals, to maximize its effectiveness. Given its diuretic effects, it is recommended to consume this medication during daylight hours or at least four hours prior to sleeping to minimize nighttime urination disruptions. The prescribing healthcare provider will determine the appropriate dosage and frequency based on the individual condition being treated, and it is essential to adhere to the prescribed regimen for the duration recommended. While using this medication, monitoring kidney health and electrolyte levels is critical. It is also beneficial to incorporate lifestyle modifications, such as a balanced diet, regular physical activity, and quitting smoking, to enhance treatment outcomes. Additionally, maintaining adequate fluid intake is suggested to alleviate dryness in the mouth and intense thirst. Prior to commencing this treatment, patients should inform their doctors about any history of circulatory issues, liver, or kidney disorders, as well as any other medications being taken to avoid potential interactions that may affect the efficacy of CTD-MT 6.25/50/40 Tablet ER.